The Latin America, Middle East and Africa Cardiovascular Information System Market would witness market growth of 12.1% CAGR during the forecast period (2023-2030).
Remote access and telemedicine have become essential components of modern healthcare. CVIS systems are adapting to this reality by offering remote access capabilities. Authorized users, including physicians and specialists, can access patient data and diagnostic images from various locations. This feature has proven invaluable in expanding the reach of cardiovascular care to remote or underserved areas and facilitating remote consultation and telemedicine, especially during the pandemic.
Another unique benefit of CVIS is its role in promoting interdisciplinary collaboration within healthcare settings. In cardiology departments and cardiovascular care facilities, various healthcare professionals collaborate to deliver comprehensive patient care, including cardiologists, radiologists, nurses, and administrators. CVIS facilitates seamless data sharing and communication among these diverse teams, ensuring that all relevant parties access the same up-to-date patient information and test results. This interdisciplinary collaboration fosters a more holistic approach to cardiovascular care, enhancing the quality of patient treatment and management.
In the Middle East and North Africa, cardiovascular disease is the leading cause of death, accounting for more than one-third of all fatalities, or 1.4 million people annually. Cardiovascular diseases are responsible for between 40% of all deaths in Oman and 10% in Somalia. In the past 30 years, there has been an increase in CVD deaths of 48% overall. Additionally, between 2000 and 2019, the prevalence of obesity in the area more than doubled. As a result, there is a growing need for efficient systems to manage cardiovascular patient data and diagnostic information, which CVIS can provide. Thus, as the LAMEA region continues to witness demographic, technological, and healthcare transformation, the adoption of CVIS is expected to rise.
The Brazil market dominated the LAMEA Cardiovascular Information System Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $40.8 Million by 2030. The Argentina market is showcasing a CAGR of 12.8% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.8% during (2023 - 2030).
Based on Type, the market is segmented into CVIS, and CPACS. Based on Mode Of Operation, the market is segmented into Web-based, Cloud-based, and On-site. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Cisco Systems, Inc., Fujifilm Holdings Corporation, Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), Lumedx Corporation (Intelerad Medical Systems Incorporated), Agfa-Gevaert Group, Honeywell International, Inc., and McKesson Corporation

Scope of the Study
Market Segments covered in the Report:
By Type

  • CVIS
  • CPACS


By Mode Of Operation

  • Web-based
  • Cloud-based
  • On-site


By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA


Companies Profiled

  • Koninklijke Philips N.V.
  • GE HealthCare Technologies, Inc.
  • Cisco Systems, Inc.
  • Fujifilm Holdings Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Cerner Corporation (Oracle Corporation)
  • Lumedx Corporation (Intelerad Medical Systems Incorporated)
  • Agfa-Gevaert Group
  • Honeywell International, Inc.
  • McKesson Corporation


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free